REPROCELL Net Income From Continuing Ops from 2010 to 2026

6RC Stock  EUR 0.57  0.00  0.00%   
REPROCELL's Net Income From Continuing Ops is increasing over the years with slightly volatile fluctuation. Overall, Net Income From Continuing Ops is expected to go to about 124.7 M this year. During the period from 2010 to 2026 REPROCELL Net Income From Continuing Ops annual values regression line had geometric mean of  487,650,922 and mean square error of 192339.6 T. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2019-03-31
Previous Quarter
-12.5 M
Current Value
-79.7 M
Quarterly Volatility
115.1 M
 
Covid
 
Interest Hikes
Check REPROCELL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among REPROCELL's main balance sheet or income statement drivers, such as Net Interest Income of 81.4 M, Interest Income of 81.4 M or Interest Expense of 0.0, as well as many indicators such as . REPROCELL financial statements analysis is a perfect complement when working with REPROCELL Valuation or Volatility modules.
  
This module can also supplement various REPROCELL Technical models . Check out the analysis of REPROCELL Correlation against competitors.
Analyzing REPROCELL's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing REPROCELL's current valuation and future prospects.

Latest REPROCELL's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of REPROCELL over the last few years. It is REPROCELL's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in REPROCELL's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

REPROCELL Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(681,089,171)
Geometric Mean487,650,922
Coefficient Of Variation(83.76)
Mean Deviation420,439,328
Median(911,665,000)
Standard Deviation570,476,558
Sample Variance325443.5T
Range2.3B
R-Value0.67
Mean Square Error192339.6T
R-Squared0.45
Significance0
Slope75,439,914
Total Sum of Squares5207096T

REPROCELL Net Income From Continuing Ops History

2026124.7 M
2025118.7 M
2024103.2 M
2023-31.4 M
2022-305.3 M
2021-575.3 M
2020-813.6 M

About REPROCELL Financial Statements

REPROCELL stakeholders use historical fundamental indicators, such as REPROCELL's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although REPROCELL investors may analyze each financial statement separately, they are all interrelated. For example, changes in REPROCELL's assets and liabilities are reflected in the revenues and expenses on REPROCELL's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in REPROCELL. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income From Continuing Ops118.7 M124.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in REPROCELL Stock

REPROCELL financial ratios help investors to determine whether REPROCELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REPROCELL with respect to the benefits of owning REPROCELL security.